Toggle light / dark theme

Brave blocks Windows Recall from screenshotting your browsing activity

Brave Software says its privacy-focused browser will block Microsoft’s Windows Recall from capturing screenshots of Brave windows by default to protect users’ privacy.

Windows Recall is an opt-in Windows feature that takes screenshots of active windows every few seconds, analyzes them, and enables Windows 11 users to search for text within the snapshots using natural language. The goal is to make it easy for users to quickly find information about past activities in Windows.

However, the feature has sparked widespread criticism for potentially exposing sensitive data of Windows users, including passwords, emails, health records, and financial information.

Can cancer drugs cure Alzheimer’s?

The team took publicly available data from three studies of the Alzheimer’s brain that measured single-cell gene expression in brain cells from deceased donors with or without Alzheimer’s disease. They used this data to produce gene expression signatures for Alzheimer’s disease in neurons and glia.

The researchers compared these signatures with those found in the Connectivity Map, a database of results from testing the effects of thousands of drugs on gene expression in human cells.

Out of 1,300 drugs, 86 reversed the Alzheimer’s disease gene expression signature in one cell type, and 25 reversed the signature in several cell types in the brain. But just 10 had already been approved by the FDA for use in humans.

Poring through records housed in the UC Health Data Warehouse, which includes anonymized health information on 1.4 million people over the age of 65, the group found that several of these drugs seemed to have reduced the risk of developing Alzheimer’s disease over time.

“Thanks to all these existing data sources, we went from 1,300 drugs, to 86, to 10, to just 5,” said the lead author of the paper.

The authors chose 2 cancer drugs out of the top 5 drug candidates for laboratory testing. They predicted one drug, letrozole, would remedy Alzheimer’s in neurons; and another, irinotecan, would help glia. Letrozole is usually used to treat breast cancer; irinotecan is usually used to treat colon and lung cancer.

The team used a mouse model of aggressive Alzheimer’s disease with multiple disease-related mutations. As the mice aged, symptoms resembling Alzheimer’s emerged, and they were treated with one or both drugs.

Study finds genetics shape health impact of leisure versus work physical activity

The benefits of exercise and its positive influence on physical and mental health are well documented, but a new Yale and VA Connecticut study sheds light on the role genetics plays for physical activity, accounting for some of the differences between individuals and showing differences in biology for physical activity at leisure versus physical activity at work and at home.

Using data from the Million Veteran Program (MVP), a genetic biobank run by the U.S. Department of Veterans Affairs, the researchers analyzed genetic influences on leisure, work, and home-time physical activity. They wanted to understand how genetics impacts these three types of physical activity and compare their health benefits.

The study included nearly 190,000 individuals of European ancestry, 27,044 of African ancestry, and 10,263 of Latin-American ancestry. To study the genetics of physical activity during leisure time, the researchers also added data from the UK Biobank, which included about 350,000 individuals.

Research uses AI to find pathologic and genetic basis for worse outcome of endometrial cancer in Black women

Endometrial cancer—in which tumors develop in the inner lining of the uterus—is the most prevalent gynecological cancer in American women, affecting more than 66,000 women a year. Black women are particularly at risk, with an 80% higher mortality rate than other demographic groups and a greater chance of contracting more aggressive cancer subtypes.

Regardless of lifestyle choices and health care equity, studies still show Black women have lower survival rates. A team of Emory researchers wondered: Could that poorer prognosis in Black women be caused by pathologic and genetic differences as well?

“Racism and equitable access to health care certainly play a big role in the increased mortality for populations of color,” says Anant Madabhushi, executive director of the Emory Empathetic AI For Health Institute. “But with endometrial cancer, it may not completely explain the difference in mortality.

An Extra Sense May Connect Gut Bacteria With Our Brain

According to new research, communication between the gut and the brain is sophisticated enough to be classed as a new and distinct sense – one capable of affecting our appetite and even our mood.

This two-way link has previously been associated with a variety of health issues, though the physical processes at work have never been clearly identified.

Building on what we already know about our digestive and neurological systems, a team from Duke University in the US traced a series of biochemical actions from the digestive tracts of mice to their brains.

Skin swabs may help detect Parkinson’s years before symptoms appear

Remote, scalable cognitive behavioral therapy–based chronic pain programs are effective for treating individuals with high-impact chronic pain.


Importance Cognitive behavioral therapy (CBT) skills training interventions are recommended first-line nonpharmacologic treatment for chronic pain, yet they are not widely accessible.

Objective To examine effectiveness of remote, scalable CBT-based chronic pain (CBT-CP) treatments (telehealth and self-completed online) for individuals with high-impact chronic pain, compared with usual care.

Design, Setting, and Participants This comparative effectiveness, 3-group, phase 3 randomized clinical trial enrolled 2,331 eligible patients with high-impact chronic musculoskeletal pain from 4 geographically diverse health care systems in the US from January 2021 through February 2023. Follow-up concluded in April 2024.

Surprising finding could pave way for universal cancer vaccine

An experimental mRNA vaccine boosted the tumor-fighting effects of immunotherapy in a mouse-model study, bringing researchers one step closer to their goal of developing a universal vaccine to “wake up” the immune system against cancer.

Published today in Nature Biomedical Engineering, the University of Florida study showed that like a one-two punch, pairing the test vaccine with common anticancer drugs called immune checkpoint inhibitors triggered a strong antitumor response.

A surprising element, researchers said, was that they achieved the promising results not by attacking a specific target protein expressed in the tumor, but by simply revving up the immune system — spurring it to respond as if fighting a virus. They did this by stimulating the expression of a protein called PD-L1 inside of tumors, making them more receptive to treatment. The research was supported by multiple federal agencies and foundations, including the National Institutes of Health.

Four-day work week benefits workers, employers, study says

A four-day work week can lead to happier and more productive, dedicated employees, a new global study found.

Workers at companies that instituted a four-day work week—essentially working 80% of their regular hours for the same pay—reported less burnout and better job satisfaction along with improved mental and physical health, researchers report in Nature Human Behavior.

“Across outcomes, the magnitude (of improvement) is larger for the two work-related measures—burnout and job satisfaction—followed by mental health, with the smallest changes reported in ,” wrote the research team co-led by Juliet Schor, an economist and sociologist at Boston College.

Suppressing tumor cell stemness might help colon cancer management

Colon cancer remains a major global health concern, ranking third among the most diagnosed cancers and the leading cause of cancer-related death worldwide. One critical factor that makes treating colon cancer challenging is the presence of cancer stem cells.

Though typically present in , these powerful cells drive tumor growth, resist standard treatments, and often contribute to relapse. They achieve this through their “stemness,” a set of properties that enable these cells to self-renew and differentiate into other cell types. Thus, understanding how stemness might be controlled at the is essential for developing effective therapies for colon cancer.

Over the past two decades, researchers have identified several key molecules involved in both the development of the colon and the progression of colon cancer. Among them are CDX1 and CDX2, two homeobox transcription factors that help establish and maintain the identity of intestinal epithelial cells.

New tool predicts cardiovascular disease risk more accurately

A new risk prediction tool developed by the American Heart Association (AHA) estimated cardiovascular disease (CVD) risk in a diverse patient cohort more accurately than current models, according to a recent study published in Nature Medicine.

The tool, called the Predicting Risk of Cardiovascular Disease EVENTs (PREVENT) equations which was developed in 2023, could help health care providers more accurately identify patients who have higher CVD risk and enhance preventive care efforts, according to Sadiya Khan, the Magerstadt Professor of Cardiovascular Epidemiology and co-first author of the study.

“Evaluating the new PREVENT equations in a diverse sample of patients is critical to provide primary care providers and cardiologists with further assurance that they can utilize these equations to accurately predict patients’ CVD risk, particularly in vulnerable populations,” said Khan, who is also an associate professor of Medical Social Sciences in the Division of Determinants of Health and of Preventive Medicine in the Division of Epidemiology.